ea0098c24 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2023
Nunez Jose E.
, Chan David L.
, Kulanthaivelu Roshini
, Murad Vanessa
, Singh Simron
, Metser Ur
Background: The clinical heterogeneity of G2 and G3 well-differentiated GEP-NENs make it difficult to choose an effective treatment plan, highlighting the need of molecular imaging in the treatment of NETs patients. It has been suggested that a dual-tracer 68Ga-DOTATATE/18F-FDG grading scoring system could be a useful imaging biomarker. This pilot study aims to validate the prior observation from Chan et al. (BJC 2022) of variability in NETPET scores in G2-G3 WD GEP NENs and a...